Bayon Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Bayon Therapeutics General Information

Description

Operator of an ophthalmic specialty pharmaceutical company dedicated to treating unmet retinal diseases. The company focuses on studying a novel class of small molecules called molecular photoswitches which have the ability to reversibly change shape based on the presence or absence of light, thereby enabling visually impaired patients to restore the eyes' ability to perceive and interpret the vision.

Contact Information

Website
www.bayontx.com
Formerly Known As
Yellowbrick Bio
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • CA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayon Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayon Therapeutics‘s full profile, request access.

Request a free trial

Bayon Therapeutics Patents

Bayon Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021372409-A1 Formulations of azobenzene photoreactive compounds Pending 27-Oct-2020
AU-2021372409-A9 Formulations of azobenzene photoreactive compounds Pending 27-Oct-2020
CA-3196120-A1 Formulations of azobenzene photoreactive compounds Pending 27-Oct-2020
EP-4236933-A1 Formulations of azobenzene photoreactive compounds Pending 27-Oct-2020
EP-4236933-A4 Formulations of azobenzene photoreactive compounds Pending 27-Oct-2020 A61K31/167
To view Bayon Therapeutics’s complete patent history, request access »

Bayon Therapeutics FAQs

  • When was Bayon Therapeutics founded?

    Bayon Therapeutics was founded in 2020.

  • Where is Bayon Therapeutics headquartered?

    Bayon Therapeutics is headquartered in CA.

  • What industry is Bayon Therapeutics in?

    Bayon Therapeutics’s primary industry is Drug Discovery.

  • Is Bayon Therapeutics a private or public company?

    Bayon Therapeutics is a Private company.

  • What is the current valuation of Bayon Therapeutics?

    The current valuation of Bayon Therapeutics is .

  • What is Bayon Therapeutics’s current revenue?

    The current revenue for Bayon Therapeutics is .

  • When was Bayon Therapeutics acquired?

    Bayon Therapeutics was acquired on 21-Oct-2021.

  • Who acquired Bayon Therapeutics?

    Bayon Therapeutics was acquired by Kiora Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process